Abstract
FLAP fingerprints are applied in the ligand-, structure- and pharmacophore-based mode in a case study on antagonists of all four adenosine receptor (AR) subtypes. Structurally diverse antagonist collections with respect to the different ARs were constructed by including binding data to human species only. FLAP models well discriminate “active” (=highly potent) from “inactive” (=weakly potent) AR antagonists, as indicated by enrichment curves, numbers of false positives, and AUC values. For all FLAP modes, model predictivity slightly decreases as follows: A2BR > A2AR > A3R > A1R antagonists. General performance of FLAP modes in this study is: ligand- > structure- > pharmacophore- based mode. We also compared the FLAP performance with other common ligand- and structure-based fingerprints. Concerning the ligand-based mode, FLAP model performance is superior to ECFP4 and ROCS for all AR subtypes. Although focusing on the early first part of the A2A, A2B and A3 enrichment curves, ECFP4 and ROCS still retain a satisfactory retrieval of actives. FLAP is also superior when comparing the structure-based mode with PLANTS and GOLD. In this study we applied for the first time the novel FLAPPharm tool for pharmacophore generation. Pharmacophore hypotheses, generated with this tool, convincingly match with formerly published data. Finally, we could demonstrate the capability of FLAP models to uncover selectivity aspects although single AR subtype models were not trained for this purpose.
Similar content being viewed by others
Abbreviations
- AR:
-
Adenosine receptors
- AUC:
-
Area under the curve
- ECFP4:
-
Extended-connectivity fingeprint
- EF:
-
Enrichment factor
- FLAP:
-
Fingerprint of ligands and proteins
- FN:
-
False negative(s)
- FP:
-
False positive(s)
- GOLD:
-
Genetic optimization of ligand docking H-bonding, hydrogen bonding
- LDA:
-
Linear discriminant analysis
- MIF:
-
Molecular interaction fields
- PLANTS:
-
Protein-ligand ant colony optimization
- QSAR:
-
Quantitative structure–activity relationships
- ROC:
-
Receiver operating characteristic
- ROCS:
-
Rapid overlay of chemical structures
References
Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J (2001) Pharmacol Rev 53(4):527
Zhou QY, Li CY, Olah ME, Johnson RA, Stiles GL, Civelli O (1992) Proc Nat Acad Sci USA 89(16):7432
Salvatore CA, Jacobson MA, Taylor HE, Linden J, Johnson RG (1993) Proc Nat Acad Sci USA 90(21):10365
Ralevic V, Burnstock G (1998) Pharmacol Rev 50(3):413
Fredholm BB (2011) Sleep Biol Rhythms 9:24
Gessi S, Merighi S, Varani K, Borea PA (2011) Advances in pharmacology (San Diego, Calif) 61:41
Mueller CE, Jacobson KA (2011) Biochimica Et Biophysica Acta-Biomembranes 1808(5):1290
Fredholm BB, Ijzerman AP, Jacobson KA, Linden J, Mueller CE (2011) Pharmacol Rev 63(1):1
Langmead CJ, Andrews SP, Congreve M, Errey JC, Hurrell E, Marshall FH, Mason JS, Richardson CM, Robertson N, Zhukov A, Weir M (2012) J Med Chem 55(5):1904
Martinelli A, Tuccinardi T (2007) Med Res Rev 28(2):247
Michielan L, Stephanie F, Terfloth L, Hristozov D, Cacciari B, Klotz K-N, Spalluto G, Gasteiger J, Moro S (2009) J Chem Inf Model 49(12):2820
Costanzi S, Tikhonova IG, Harden TK, Jacobson KA (2009) J Comput Aided Mol Des 23(11):747
Goddard WA III, Kim S-K, Li Y, Trzaskowski B, Griffith AR, Abrol R (2010) J Struct Biol 170(1):10
Wei J, Wang S, Gao S, Dai X, Gao Q (2007) J Chem Inf Model 47(2):613
Tafi A, Bernardini C, Botta M, Corelli F, Andreini M, Martinelli A, Ortore G, Baraldi PG, Fruttarolo F, Borea PA, Tuccinardi T (2006) J Med Chem 49(14):4085
Cheong SL, Federico S, Venkatesan G, Paira P, Shao Y-M, Spalluto G, Yap CW, Pastorin G (2011) Bioorg Med Chem Lett 21(10):2898
Xu Z, Cheng F, Da C, Liu G, Tang Y (2010) J Mol Model 16(12):1867
Cheng F, Xu Z, Liu G, Tang Y (2010) Eur J Med Chem 45(8):3459
Wei J, Li H, Qu W, Gao Q (2009) Neurochem Int 55(7):637
Yaziji V, Rodriguez D, Gutierrez-de-Teran H, Coelho A, Caamano O, Garcia-Mera X, Brea J, Isabel Loza M, Isabel Cadavid M, Sotelo E (2011) J Med Chem 54(2):457
Faller B, Ottaviani G, Ertl P, Berellini G, Collis A (2011) Drug Discov Today 16(21–22):976
Baroni M, Cruciani G, Sciabola S, Perruccio F, Mason JS (2007) J Chem Inf Model 47(2):279
Cross S, Baroni M, Carosati E, Benedetti P, Clementi S (2010) J Chem Inf Model 50(8):1442
Grant JA, Gallardo MA, Pickup BT (1996) J Comput Chem 17(14):1653
Rogers D, Hahn M (2010) J Chem Inf Model 50(5):742
Korb OS, Exner TE (2007) Swarm Intell 1:115
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) J Mol Biol 267:727
Gasteiger J, Teckentrup A, Terfloth L, Spycher S (2003) J Phys Org Chem 16(4):232
Milletti F, Storchi L, Sforna G, Cruciani G (2007) J Chem Inf Model 47:2172
Cruciani C, Crivori P, Carrupt PA, Testa B (2000) J Mol Struct Theochem 503(1–2):17
Cruciani G, Pastor M, Guba W (2000) Eur J Pharm Sci 11:S29
Hudson BD, Hyde RM, Rahr E, Wood J (1996) Quant Struct-Act Relat 15(4):285
Carosati E, Sciabola S, Cruciani G (2004) J Med Chem 47(21):5114
Brincat JP, Carosati E, Sabatini S, Manfroni G, Fravolini A, Raygada JL, Pate D, Kaatz GW, Cruciani G (2011) J Med Chem 54(1):354
Carosati E, Mannhold R, Wahl P, Hansen JB, Fremming T, Zamora I, Cianchetta G, Baroni M (2007) J Med Chem 50(9):2117
Sciabola S, Stanton RV, Mills JE, Flocco MM, Baroni M, Cruciani G, Perruccio F, Mason JS (2010) J Chem Inf Model 50:155
Cross S, Baroni M, Goracci L, Cruciani G (2012) J Chem Inf Model 21:21
Cross S, Ortuso F, Baroni M, Costa G, Distinto S, Moraca F, Alcaro S, Cruciani G (2012) J Chem Inf Model 21:21
Bostrom J, Greenwood JR, Gottfries J (2003) J Mol Graph Model 21(5):449
Morgan HL (1965) J Chem Doc 5(2):107
Jaakola V-P, Griffith MT, Hanson MA, Cherezov V, Chien EYT, Lane JR, Ijzerman AP, Stevens RC (2008) Science 322(5905):1211
Rodriguez D, Pineiro A, Gutierrez-de-Teran H (2011) Biochemistry 50(19):4194
Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) Nucleic Acids Res 25(24):4876
Sali A, Blundell TL (1993) J Mol Biol 234(3):779
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) J Appl Crystallog 26:283
Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB, 3rd, Snoeyink J, Richardson JS, Richardson DC (2007) Nucleic Acids Res 35(Web Server issue):W375
Fiser A, Do RK, Sali A (2000) Protein Sci 9(9):1753
Macromodel, version 9.7, Schrödinger L, New York, NY, 2009
Korb O, Stutzle T, Exner TE (2009) J Chem Inf Model 49(1):84
Ballesteros JA, Weinstein H (1995) Methods Neurosci 25:366
Xu F, Stevens Raymond C (2011) Structure (London, England: 1993) 19(9):1204
Oprea TI, Gottfries J (2001) J Comb Chem 3(2):157
Fisher RA (1936) Ann Eugen 7:179
Mc Lachlan GJ (2004) Wiley series in probability and statistics
Jacobson KA, Linden J (2011) Advances in pharmacology 61 (XV–XVI)
Chang LCW, Spanjersberg RF, Kunzel JKVFD, Brussee J, Ijzerman AP (2006) J Med Chem 49(10):2861
Scheiff AB, Yerande SG, El-Tayeb A, Li W, Inamdar GS, Vasu KK, Sudarsanam V, Mueller CE (2010) Bioorg Med Chem 18(6):2195
Ferrarini PL, Betti L, Cavallini T, Giannaccini G, Lucacchini A, Manera C, Martinelli A, Ortore G, Saccomanni G, Tuccinardi T (2004) J Med Chem 47(12):3019
Novellino E, Cosimelli B, Ehlardo M, Greco G, Iadanza M, Lavecchia A, Rimoli MG, Sala A, Da Settimo A, Primofiore G, Da Settimo F, Taliani S, La Motta C, Klotz KN, Tuscano D, Trincavelli ML, Martini C (2005) J Med Chem 48(26):8253
Manetti F, Schenone S, Bondavalli F, Brullo C, Bruno O, Ranise A, Mosti L, Menozzi G, Fossa P, Trincavelli ML, Martini C, Martinelli A, Tintori C, Botta M (2005) J Med Chem 48(23):7172
Sirci F, Istyastono EP, Vischer HF, Kooistra AJ, Nijmeijer S, Kuijer M, Wijtmans M, Mannhold R, Leurs R, Esch IJPd, Graaf Cd (2012) J Chem Inf Model (submittted)
Kim SK, Gao ZG, Van Rompaey P, Gross AS, Chen A, Van Calenbergh S, Jacobson KA (2003) J Med Chem 46(23):4847
Kim JH, Wess J, Schoneberg T, Jacobson KA (1995) J Biol Chem 270:13987
Piirainen H, Ashok Y, Nanekar RT, Jaakola V-P (2011) Biochimica Et Biophysica Acta-Biomembranes 1808(5):1233
Ivanov AA, Baskin II, Palyulin VA, Piccagli L, Baraldi PG, Zefirov NS (2005) J Med Chem 48(22):6813
Ivanov AA, Barak D, Jacobson KA (2009) J Med Chem 52(10):3284
Gao ZG, Chen A, Barak D, Kim SK, Muller CE, Jacobson KA (2002) J Biol Chem 277(21):19056
Dore AS, Robertson N, Errey JC, Ng I, Hollenstein K, Tehan B, Hurrell E, Bennett K, Congreve M, Magnani F, Tate CG, Weir M, Marshall FH (2011) Structure 19(9):1283
Weyler S, Fuelle F, Diekmann M, Schumacher B, Hinz S, Klotz K-N, Mueller CE (2006) ChemMedChem 1(8):891
Elzein E, Rao KA, Li XF, Perry T, Parkhill E, Palle V, Varkhedkar V, Gimbel A, Zeng DW, Lustig D, Leung K, Zablocki J (2006) Bioorg Med Chem Lett 16(2):302
Kalla RV, Elzein E, Perry T, Li X, Gimbel A, Yang M, Zeng D, Zablocki J (2008) Bioorg Med Chem Lett 18(4):1397
Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA (2004) J Med Chem 47(6):1434
Baraldi PG, Tabrizi MA, Bovero A, Avitabile B, Preti D, Fruttarolo F, Romagnoli R, Varani K, Borea PA (2003) Eur J Med Chem 38(4):367
Baraldi PG, Cacciari B, Moro S, Spalluto G, Pastorin G, Da Ros T, Klotz KN, Varani K, Gessi S, Borea PA (2002) J Med Chem 45(4):770
Afzelius L, Raubacher F, Karlen A, Jorgensen FS, Andersson TB, Masimirembwa CM, Zamora I (2004) Drug Metab Dispos 32(11):1218
Hino T, Arakawa T, Iwanari H, Yurugi-Kobayashi T, Ikeda-Suno C, Nakada-Nakura Y, Kusano-Arai O, Weyand S, Shimamura T, Nomura N, Cameron AD, Kobayashi T, Hamakubo T, Iwata S, Murata T (2012) Nature 482(7384):237
Gao ZG, Kim SK, Biadatti T, Chen WZ, Lee K, Barak D, Kim SG, Johnson CR, Jacobson KA (2002) J Med Chem 45(20):4471
Jacobson KA, Gao ZG, Chen AS, Barak D, Kim SA, Lee K, Link A, Van Rompaey P, van Calenbergh S, Liang BT (2001) J Med Chem 44(24):4125
Katritch V, Kufareva I, Abagyan R (2011) Neuropharmacology 60(1):108
Xu F, Wu H, Katritch V, Han GW, Jacobson KA, Gao Z-G, Cherezov V, Stevens RC (2011) Science 332(6027):322
Lenzi O, Colotta V, Catarzi D, Varano F, Poli D, Filacchioni G, Varani K, Vincenzi F, Borea PA, Paoletta S, Morizzo E, Moro S (2009) J Med Chem 52(23):7640
Congreve M, Andrews SP, Doré AS, Hollenstein K, Hurrell E, Langmead CJ, Mason JS, Ng WI, Tehan B, Zhukov A, Weir M, Marshall FH (2012) J Med Chem 55:1898
Zhang X, Rueter JK, Chen Y, Moorjani M, Lanier MC, Lin E, Gross RS, Tellew JE, Williams JP, Lechner SM, Markison S, Joswig T, Malany S, Santos M, Castro-Palomino JC, Crespo MI, Prat M, Gual S, Diaz J-L, Saunders J, Slee DH (2008) Bioorg Med Chem Lett 18(6):1778
Borrmann T, Hinz S, Lertarelli DCG, Li W, Florin NC, Scheiff AB, Mueller CE (2009) J Med Chem 52(13):3994
Stefanachi A, Nicolotti O, Leonetti F, Cellamare S, Campagna F, Isabel Loza M, Manuel Brea J, Mazza F, Gavuzzo E, Carotti A (2008) Bioorg Med Chem 16(22):9780
Kim YC, Ji XD, Jacobson KA (1996) J Med Chem 39(21):4142
van Muijlwijk-Koezen JE (2001) PhD thesis
Acknowledgments
We thank Molecular Discovery Ltd. for granting FLAP suite license. We also thank Lydia Siragusa for assisting us in the Protein–Protein study.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sirci, F., Goracci, L., Rodríguez, D. et al. Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A1, A2A, A2B, and A3 receptor antagonists. J Comput Aided Mol Des 26, 1247–1266 (2012). https://doi.org/10.1007/s10822-012-9612-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-012-9612-8